Dup15q Syndrome Drug Market is Projected to Grow Significantly During the Study Period (2019–2032) | DelveInsight
February 27, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Dup15q Syndrome Drug Market is Projected to Grow Significantly During the Study Period (2019–2032) | DelveInsight An increase in the prevalence,...
Follicular Lymphoma Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies - AbbVie, Genmab, Novartis, Allogene Therapeutics, Pfizer, Genentech, Incyte Corporation, Bristol-Myers Squibb
February 26, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Follicular Lymphoma Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies - AbbVie, Genmab, Novartis, Allogene...
Short Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsight
February 22, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Short Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsight The dynamics of the short...
Ascites Market to Observe Stunning Growth During the Study Period (2019–2032) | DelveInsight
February 21, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Ascites Market to Observe Stunning Growth During the Study Period (2019–2032) | DelveInsight The rise in the patient population of ascites, the...
PD-1 and PD-L1 Inhibitors Market is Projected to Grow Rapidly During the Study Period (2019–2032) | DelveInsight
February 20, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- PD-1 and PD-L1 Inhibitors Market is Projected to Grow Rapidly During the Study Period (2019–2032) | DelveInsight The PD-1 and PD-L1 inhibitor...
Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
February 19, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment |...
Burns Market is Projected to Grow During the Study Period (2019–2032), Predicts DelveInsight | Key Players in the Market - Aegle Therapeutics, Skingenix, Inc., Stratatech, MediWound Ltd
February 15, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Burns Market is Projected to Grow During the Study Period (2019–2032), Predicts DelveInsight | Key Players in the Market - Aegle Therapeutics,...
Gene and Cell Therapies Targeting CNS Disorders Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight
February 14, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Gene and Cell Therapies Targeting CNS Disorders Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight The gene and cell...
Diabetic Foot Ulcers Market to Witness Upsurge Growth by 2032, Estimates DelveInsight | Leading Companies - Anterogen Co., Lavior Pharma, Vitruvian Medical Devices, Oneness Biotech Co., Energenesis Biomedical Co.
February 13, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Diabetic Foot Ulcers Market to Witness Upsurge Growth by 2032, Estimates DelveInsight | Leading Companies - Anterogen Co., Lavior Pharma, Vitruvian...
Primary Hyperoxaluria Market to Exhibit Substantial Growth Rate by 2032, Assesses DelveInsight | Leading Companies - Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, OxThera, Allena Pharmaceuticals, Biocodex
February 12, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Primary Hyperoxaluria Market to Exhibit Substantial Growth Rate by 2032, Assesses DelveInsight | Leading Companies - Alnylam Pharmaceuticals, Dicerna...